Please use this identifier to cite or link to this item:
|Title:||Cardiotoxicity testing using pluripotent stem cell‐derived human cardiomyocytes and state‐of‐the‐art bioanalytics: a review|
|Authors:||MANDENIUS CARL-FREDERIK; STEEL DANIELA; NOOR FOZIA; MEYER THOMAS; HEINZELE ELMAR; ASP JULIA; ARAIN SARINA; KRAUSHAAR UDO; BREMER SUSANNE; CLASS REINER; SARTIPY PETER|
|Citation:||JOURNAL OF APPLIED TOXICOLOGY vol. 31 no. 3 p. 191-205|
|Publisher:||JOHN WILEY & SONS LTD|
|Type:||Articles in periodicals and books|
|Abstract:||In this article, recent progress in cardiotoxicity testing based on the use of immortalized cell lines or human embryonic stem cell (hESC) derived cardiomyocytes in combination with state‐of‐the‐art bioanalytical methods and sensors is reviewed. The focus is on hESC‐derived cells and their refinement into competent testing cells, but the access and utility of other relevant cell types are also discussed. Recent developments in sensor techniques and bioanalytical approaches for measuring critical cardiotoxicity parameters are highlighted, together with aspects of data evaluation and validation. Finally, recommendations for further research are given.|
|JRC Directorate:||Health, Consumers and Reference Materials|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.